| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |